| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥9506.4B | ¥9110.6B | +4.3% |
| Operating Income | ¥219.5B | ¥224.4B | -2.2% |
| Ordinary Income | ¥245.5B | ¥254.2B | -3.4% |
| Net Income | ¥173.2B | ¥182.8B | -5.3% |
| ROE | 5.8% | 6.4% | - |
FY2026 Q3 (9-month cumulative) results: Revenue 950.6 billion yen (YoY +4.3%), Operating Income 21.9 billion yen (YoY -2.2%), Ordinary Income 24.5 billion yen (YoY -3.4%), Net Income 17.3 billion yen (YoY -5.3%). The company achieved revenue growth driven by new account acquisitions, expanded product offerings in high-value categories, inbound tourist demand, and seasonal merchandise strength. However, profitability declined as selling, general and administrative expenses rose 8.6% YoY, primarily due to personnel costs (+1.6 billion yen) and delivery costs (+1.1 billion yen), compressing operating margin to 2.31% from 2.46% in the prior year. The company maintained full-year guidance of revenue 1.23 trillion yen (+3.5%) and operating income 29.0 billion yen (+3.5%), requiring margin recovery in the second half through gross margin improvement and cost control measures.
Revenue growth of 4.3% was driven by multiple factors: new account acquisitions, expanded offerings in value-added categories (health foods, outbound-related cosmetics), continued inbound tourist demand for cosmetics, and strong seasonal merchandise performance in daily goods due to colder weather. By category, Daily Goods grew 5.9% to 428.1 billion yen, Cosmetics increased 5.2% to 226.7 billion yen, and Health & Hygiene products rose 3.9% to 168.1 billion yen. Pharmaceuticals declined 2.4% to 110.8 billion yen due to lower demand for certain cold remedies and beverage supplements.
Despite revenue growth, operating profit declined 2.2% as gross profit growth (+5.0% to 71.4 billion yen) was more than offset by a sharp increase in SG&A expenses (+8.6% to 49.5 billion yen). The SG&A ratio rose 0.21pt to 5.21%, driven by personnel costs increasing 1.6 billion yen and delivery costs rising 1.1 billion yen. Delivery unit costs surged 9.3% YoY, reflecting persistent labor shortages and logistics inflation. Warehouse operations showed signs of stabilization in Q3, with bulk-line productivity improving from Q2, though external warehouse rental increased upfront costs.
Ordinary income decreased 3.4% to 24.5 billion yen, with non-operating income of 2.6 billion yen (including dividend income of 0.4 billion yen) and non-operating expenses of 0.4 billion yen. Net income declined 5.3% to 17.3 billion yen, with an effective tax rate of 30.8%. The gap between ordinary and net income reflects a 2.0 billion yen gain on reversal of investment partnership interests (non-recurring item). Basic EPS declined to 281.57 yen from 292.09 yen in the prior year.
This represents a "revenue up, profit down" pattern, primarily attributable to logistics cost inflation outpacing operational efficiency improvements. The company's warehouse productivity initiatives have begun to show results (bulk-line efficiency improved vs Q2), but delivery cost escalation remains a structural challenge requiring sustained green logistics initiatives and collaborative delivery arrangements.
By merchandise category, Daily Goods (45.0% of revenue) represents the core business, contributing 428.1 billion yen in cumulative revenue (+5.9% YoY) and 146.3 billion yen in Q3 alone (+6.1%). This segment drove overall revenue growth, benefiting from strong performance in toys, oral care products, and seasonal items (heating-related goods) due to colder temperatures.
Cosmetics contributed 226.7 billion yen (+5.2% YoY) in cumulative revenue and 75.3 billion yen in Q3 (+5.2%). Growth was supported by inbound tourist demand and outbound-related merchandise, as well as strong seasonal cosmetics (winter skincare products). This segment maintained solid momentum throughout the period.
Health & Hygiene products generated 168.1 billion yen in cumulative revenue (+3.9% YoY) and 58.9 billion yen in Q3 (+6.2%). Supplements and health-oriented products performed well reflecting continued health consciousness, though sanitary items including masks declined from elevated prior-year levels.
Pharmaceuticals recorded 110.8 billion yen in cumulative revenue (-2.4% YoY) and 38.4 billion yen in Q3 (-2.3%), the only declining segment. Weakness in certain cold remedies, beverage supplements, and other pharmaceutical categories offset growth elsewhere.
Other operations (primarily logistics outsourcing services) contributed 16.6 billion yen (+6.4% YoY) and 6.3 billion yen in Q3 (+1.6%), with growth driven by expanded third-party logistics volumes.
Segment-level operating profit margins are not disclosed, but the company indicated that gross margin structure varies significantly by category, with value-added health and cosmetics categories offering higher margins than commodity daily goods. The overall operating margin compression from 2.46% to 2.31% suggests that SG&A cost increases affected all segments uniformly rather than being isolated to specific categories.
Profitability: ROE 5.8% (calculated via DuPont analysis: 1.8% net margin × 1.748 asset turnover × 1.81 financial leverage), Operating Margin 2.3% (prior year 2.5%), Net Margin 1.8%, Gross Margin 7.5% (prior year 7.8%). EBIT Margin 2.3%, representing a decline of 0.15pt YoY.
Cash Quality: OCF/Net Income 0.48x (below healthy 1.0x threshold, indicating earnings quality concerns), FCF 5.9 billion yen (Operating CF 8.4 billion yen minus CapEx 1.6 billion yen), Cash Conversion Ratio 0.31 (indicating significant working capital absorption).
Investment: CapEx/Depreciation 0.34x (1.6 billion yen CapEx vs 4.8 billion yen depreciation), indicating conservative capital investment posture rather than growth-phase expansion. The company is utilizing external leased warehouse facilities rather than investing in owned infrastructure.
Financial Health: Equity Ratio 55.1% (299.8 billion yen equity / 543.9 billion yen total assets), Current Ratio 172.4% (398.0 billion yen current assets / 230.9 billion yen current liabilities), Quick Ratio 143.3%, Debt-to-Equity Ratio 0.81x. Financial leverage 1.81x.
Efficiency: Asset Turnover 1.748x, Inventory Turnover approximately 51 days, Receivables Turnover (DSO) approximately 93 days (elevated, indicating collection challenges), Payables Turnover approximately 76 days.
Operating CF: 8.4 billion yen, representing 0.48x Net Income (well below the healthy 1.0x threshold, flagging significant earnings quality concerns). The weak cash conversion stems from working capital increases, specifically trade receivables increasing 23.6 billion yen and inventory build-up. Operating cash generation was constrained by the timing of receivables collection and inventory positioning for seasonal demand.
Investing CF: -2.5 billion yen, primarily consisting of CapEx of 1.6 billion yen. The company maintained conservative capital expenditure at 0.34x depreciation, opting to utilize external leased warehouse capacity rather than investing in owned facilities. This approach minimizes upfront capital requirements but increases operating lease expenses.
Financing CF: -9.7 billion yen, comprising dividends paid of 6.3 billion yen (interim 50 yen per share) and share buybacks of 2.7 billion yen executed during the period. The company returned capital to shareholders despite constrained operating cash flow.
FCF: 5.9 billion yen (Operating CF 8.4 billion yen minus CapEx 1.6 billion yen). FCF coverage ratio of shareholder returns: 0.91x (FCF 5.9 billion yen / total returns of dividends plus buybacks 6.5 billion yen), indicating that free cash flow did not fully cover total capital returns in the period.
Cash generation assessment: Needs Monitoring. The OCF/Net Income ratio of 0.48x and cash conversion ratio of 0.31 indicate structural issues in converting accounting profits into cash. Working capital efficiency, particularly receivables collection (DSO 93 days) and inventory management, requires improvement. The company's ability to sustain shareholder returns at current levels depends on second-half cash flow recovery.
Ordinary Income of 24.5 billion yen exceeded Net Income of 17.3 billion yen by 7.2 billion yen, primarily due to income tax expenses of 7.7 billion yen (effective tax rate 30.8%). Within non-operating items, the company recorded a 2.0 billion yen gain on reversal of investment partnership interests, which represents a non-recurring item. Adjusting for this, recurring ordinary income would approximate 22.5 billion yen.
Non-operating income totaled 2.6 billion yen (0.3% of revenue), including dividend income of 0.4 billion yen, interest income, and the aforementioned investment partnership reversal gain. Non-operating expenses of 0.4 billion yen primarily consisted of interest expense of 0.05 billion yen (resulting in an extraordinarily high interest coverage ratio of 4389x, indicating negligible debt service burden).
The primary earnings quality concern stems from accruals rather than non-operating items. Operating CF of 8.4 billion yen trailing Net Income of 17.3 billion yen by 52% indicates that more than half of reported profits did not convert to cash in the period. This divergence is attributable to working capital increases (receivables +23.6 billion yen outflow, inventory build-up) rather than aggressive revenue recognition or expense deferral policies. The company's presentation materials acknowledge warehouse operations beginning to stabilize in Q3 and cite external warehouse rental as a deliberate capacity management strategy, suggesting operational factors rather than accounting manipulation drive the cash-earnings gap.
Sustainability assessment: Core operating profitability appears sustainable given stable market share and category expansion, but cash realization requires working capital efficiency improvements. The non-recurring investment partnership gain of 2.0 billion yen should be excluded when evaluating run-rate profitability.
Full-year guidance maintained at Revenue 1.23 trillion yen (+3.5% YoY), Operating Income 29.0 billion yen (+3.5%), Ordinary Income 32.2 billion yen (+1.6%), Net Income 22.0 billion yen (-3.8%). Annual dividend projection of 63 yen per share (interim 50 yen paid, year-end 55 yen planned) remains unchanged.
Q3 cumulative progress rates: Revenue 77.3% (950.6 billion yen / 1,230 billion yen target), Operating Income 75.7% (21.9 billion yen / 29.0 billion yen target). Progress rates are slightly ahead of the linear 75% standard for Q3 (9 months / 12 months), indicating guidance is within reach assuming second-half execution.
The guidance implies Q4 requirements of: Revenue 279.4 billion yen (+1.8% YoY), Operating Income 7.1 billion yen (+21.4% YoY). Q4 operating margin would need to reach 2.54%, a 0.23pt improvement from Q3's 2.31% and 0.39pt above H1 average. This margin recovery assumes realization of the company's stated initiatives: gross margin improvement through value-added product mix enhancement, SG&A cost control through retailer collaboration and green logistics efficiency gains, and working capital efficiency improvements to strengthen cash flow.
Key guidance assumptions: continued moderate revenue growth driven by account expansion and inbound demand, stabilization of warehouse operational efficiency following Q3 improvements, persistent delivery cost inflation requiring ongoing mitigation efforts, and normalized seasonal merchandise patterns. The company did not revise guidance despite Q3 profit decline, signaling management confidence in second-half margin recovery initiatives.
Dividend policy: Interim dividend of 50 yen per share paid, with year-end dividend planned at 55 yen per share for a full-year total of 63 yen. Based on 62.0 million shares outstanding and Net Income of 17.3 billion yen, the calculated payout ratio is approximately 37.6% (63 yen × 62.0 million shares = 3.9 billion yen annualized / 23.1 billion yen full-year net income projection), within sustainable range.
Share buyback: The company executed 2.7 billion yen in buybacks during the 9-month period, resulting in treasury stock increasing to -4.1 billion yen (from -5.8 billion yen prior year-end). Combined with dividends, total capital returns approximated 6.5 billion yen for the 9 months.
Total return ratio: Combining dividends (3.9 billion yen annualized estimate) and buybacks (2.7 billion yen actual), total shareholder returns approach 6.6 billion yen against cumulative net income of 17.3 billion yen, implying a total return ratio of approximately 38% for the period. However, FCF coverage ratio of 0.91x indicates that free cash flow of 5.9 billion yen fell short of covering these total returns, necessitating working capital optimization or balance sheet cash utilization.
Sustainability assessment: The dividend payout ratio of 37.6% appears sustainable based on profitability, and the company's balance sheet strength (equity ratio 55.1%, cash holdings 66.1 billion yen) provides capacity to maintain returns in the near term. However, the combination of weak operating cash conversion (OCF/Net Income 0.48x) and total returns exceeding FCF creates medium-term pressure. Sustained shareholder returns at current levels require second-half cash flow improvement through working capital efficiency gains, particularly receivables collection (DSO reduction) and inventory optimization.
Near-term:
Long-term:
Industry Position (Reference - Proprietary Analysis)
Profitability: Operating Margin 2.3% vs industry median 3.2% (trading sector, 2025-Q3, n=15), positioning below median. Net Margin 1.8% vs industry median 2.0%, also slightly below median. ROE 5.8% (calculated) vs industry median 3.7%, above median. ROA 3.2% (calculated) vs industry median 2.3%, above median. The company's asset efficiency (turnover 1.748x vs median 1.06x) partially compensates for below-median operating margins to deliver above-median ROE.
Efficiency: Asset Turnover 1.748x vs industry median 1.06x, significantly above median, reflecting the company's high-velocity wholesale business model. Receivables Turnover (DSO) approximately 93 days vs industry median 73.6 days (IQR 64.8-91.1 days), indicating slower collection than typical peers. Inventory Turnover approximately 51 days vs industry median 51.0 days (IQR 30.5-74.7 days), in line with median. Operating Working Capital Cycle not calculable from available data but elevated receivables suggest extended cash conversion cycles.
Financial Health: Equity Ratio 55.1% vs industry median 47.8% (IQR 43.0%-55.5%), at the high end of the range indicating conservative capital structure. Current Ratio 172.4% vs industry median 188% (IQR 164%-238%), slightly below median but within healthy range. Financial Leverage 1.81x vs industry median 1.97x (IQR 1.80-2.33), below median consistent with higher equity ratio.
Growth: Revenue Growth 4.3% vs industry median 2.6% (IQR -5.3% to +10.8%), above median. EPS Growth -5.3% (net income decline) vs industry median +31% (IQR -6% to +197%), significantly below median, reflecting margin compression challenges.
Valuation: Net Debt/EBITDA position cannot be calculated from provided data, though industry median of -2.14 (IQR -6.31 to -0.01, n=14) suggests most trading companies maintain net cash positions.
Industry: Trading sector (n=15 companies), Comparison period: 2025-Q3 (9-month cumulative results), Source: Proprietary analysis of publicly available earnings data.
Summary: PALTAC demonstrates above-median revenue growth and asset efficiency, translating to above-median ROE despite below-median operating margins. The company's primary competitive disadvantages are margin compression (2.3% operating margin vs 3.2% industry median) and earnings quality (OCF/Net Income 0.48x) stemming from logistics cost inflation and working capital inefficiency. The elevated equity ratio and strong current ratio provide financial flexibility to weather near-term margin pressures while implementing efficiency initiatives.
Logistics cost inflation risk (quantified at delivery unit cost +9.3% YoY, personnel costs +1.6 billion yen cumulative): Persistent labor shortages and transportation market tightness continue to drive delivery and warehouse costs upward, compressing operating margins by 0.15pt to 2.3%. The company's gross margin of 7.5% provides limited buffer against further cost escalation. If delivery cost inflation persists at high single-digit rates without offsetting pricing power or efficiency gains, operating margin could deteriorate toward 2.0% or below, jeopardizing full-year guidance and medium-term profitability targets. Mitigation depends on successful execution of green logistics initiatives (collaborative delivery, relay hub utilization, external warehouse optimization) and potential industry-wide pricing adjustments.
Working capital efficiency and cash conversion risk (quantified at OCF/Net Income 0.48x, DSO 93 days vs peer median 74 days, FCF coverage 0.91x): The company's inability to convert over 50% of accounting profits into operating cash flow stems from extended receivables collection cycles and inventory build-up. If working capital efficiency does not improve in Q4, operating cash flow would fall short of covering normalized shareholder returns (dividends plus buybacks), requiring balance sheet cash drawdown or curtailment of capital returns. With DSO at 93 days (19 days above peer median), a 10-day reduction would release approximately 26 billion yen in working capital (950.6 billion revenue × 10 days / 365 days), significantly enhancing cash flexibility. Failure to improve working capital efficiency creates medium-term constraints on growth investment and shareholder return sustainability.
Market share and margin sustainability in value-segment products risk: The company operates in a structurally low-margin wholesale business (gross margin 7.5%, operating margin 2.3%) serving price-sensitive retail channels. Ongoing consumer preference for value-oriented purchasing amid inflation creates pricing pressure, while direct-to-consumer channels and e-commerce disintermediation pose structural threats to traditional wholesale models. The company's strategy of expanding value-added categories (health supplements, premium cosmetics) and third-party logistics services aims to enhance margins, but these segments remain a minority of revenue. If core daily goods and commodity pharmaceutical categories face sustained pricing pressure or volume declines, and higher-margin category expansion fails to accelerate, the company's ability to maintain 2-3% operating margins while absorbing logistics cost inflation becomes increasingly challenged. The Pharmaceuticals segment already contracted 2.4% in the period, indicating vulnerability in certain categories.
Cash flow coverage gap (FCF 5.9 billion yen vs total shareholder returns 6.5 billion yen in 9 months): The company executed 2.7 billion yen in share buybacks despite operating cash flow of only 8.4 billion yen (0.48x net income). Combined with dividend payments, total capital returns exceeded free cash flow generation by approximately 10%, requiring balance sheet cash utilization. With cash holdings of 66.1 billion yen and strong equity ratio of 55.1%, near-term liquidity is not at risk. However, if operating cash generation does not improve (requires working capital efficiency gains), the company faces a choice between curtailing buybacks or depleting cash reserves, limiting strategic flexibility for growth investments or M&A opportunities.
Operating leverage and fixed cost burden: SG&A expenses of 49.5 billion yen increased 8.6% YoY, outpacing revenue growth of 4.3%, indicating negative operating leverage. Personnel costs (+1.6 billion yen) and delivery costs (+1.1 billion yen) exhibit fixed or semi-fixed characteristics that cannot be rapidly adjusted to revenue fluctuations. The company's external warehouse rental strategy, while avoiding upfront CapEx, increases fixed rental and operating expenses. If revenue growth decelerates below current 4-5% levels or turns negative, the company's thin 2.3% operating margin would compress rapidly, potentially turning unprofitable at segment or overall levels without swift cost restructuring.
Capital allocation pressure: With conservative CapEx (1.6 billion yen, 0.34x depreciation), the company is under-investing in owned infrastructure, relying instead on external leased facilities. This approach preserves near-term cash but may result in higher long-term operating costs and reduced operational control. If logistics capacity constraints intensify or rental rates escalate, the company may face a costly pivot toward capital-intensive owned facility investments at a time when cash generation is already constrained. The low CapEx/depreciation ratio of 0.34x also suggests potential for asset aging in core distribution infrastructure, creating medium-term reinvestment requirements that could compete with shareholder return commitments.
Operational inflection point: Q3 results demonstrate early signs of warehouse efficiency stabilization following prolonged productivity headwinds, with bulk-line operations showing improvement versus Q2 and external leased facility utilization addressing capacity constraints. If this operational stabilization proves sustainable and translates to visible cost leverage in Q4, the company's ability to achieve full-year guidance (requiring Q4 operating margin of 2.54%, up 0.23pt from Q3's 2.31%) would be validated, potentially signaling a turning point in the margin compression trend observed over recent quarters. The green logistics initiatives recognized by national government award suggest structural efficiency improvements rather than temporary cyclical factors, supporting medium-term margin recovery potential.
Cash flow quality as determinant of return sustainability: The most significant characteristic observed in the earnings data is the material divergence between accounting profitability and cash generation (OCF/Net Income 0.48x, cash conversion ratio 0.31). This divergence, driven by working capital absorption rather than accounting quality issues, creates a binding constraint on the company's capital allocation flexibility. Second-half improvement in working capital efficiency, particularly receivables collection (DSO reduction from 93 days toward peer median of 74 days), represents the critical path for sustaining dividend growth and opportunistic buybacks without depleting balance sheet cash. The company's strong equity ratio of 55.1% and current ratio of 172.4% provide a multi-quarter buffer, but trends rather than absolute levels warrant close monitoring.
Strategic positioning in category mix evolution: The earnings data reveals differentiated growth rates across merchandise categories, with value-added segments (Health & Hygiene +3.9%, Cosmetics +5.2%) outpacing traditional pharmaceuticals (-2.4%). This category mix shift, combined with third-party logistics service expansion (Other segment +6.4%), suggests gradual business model evolution toward higher-value-added activities beyond commodity wholesale distribution. The sustainability of above-peer revenue growth (4.3% vs industry median 2.6%) depends on the company's ability to accelerate penetration of these higher-growth, higher-margin categories while managing mature category optimization. The company's asset efficiency advantage (turnover 1.75x vs industry median 1.06x) provides operating leverage that, if combined with margin improvement, could drive above-peer earnings growth once logistics cost headwinds stabilize.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI analysis of PDF earnings presentation
For PALTAC (8283), in the fiscal year ending March 2026, third quarter cumulative (Apr–Dec) results delivered net sales of 9,506 hundred million yen (YoY +4.3%), achieving top-line growth, but operating income declined to 219 hundred million yen (YoY -2.2%). In an environment of persistent frugality, account wins, expansion of new value-added product categories, inbound demand, and strong seasonal items drove sales. Meanwhile, higher logistics-related costs such as personnel and delivery expenses raised the SG&A ratio, pushing the operating margin down to 2.31% (YoY -0.15pt). Although in-warehouse work efficiency bottomed versus 2Q (improved piece-pick line productivity), the rise in delivery unit prices (+9.3%) remains a headwind. Financial cash outflows expanded due to share buybacks (-27.24 hundred million yen). Full-year guidance (sales 1.23 trillion yen, operating income 290 hundred million yen) was maintained, with gross margin improvement and SG&A containment in 2H being key to achievement.
Net sales 9,506 hundred million yen (+4.3%): account wins, expansion of value-added product offerings, inbound demand, and seasonal items contributed. Hygiene-related items and some pharmaceuticals declined. Operating income 219 hundred million yen (-2.2%): gross profit increased (+5.0%) but higher SG&A (+8.6%) compressed earnings. 3rd quarter (Oct–Dec) net sales 3,255 hundred million yen (+4.8%), operating income 80 hundred million yen (-4.8%). Daily necessities and seasonal cosmetics were strong; pharmaceuticals edged down. SG&A ratio 5.21% (+0.21pt): personnel expenses +16 hundred million yen and delivery expenses +11 hundred million yen were the main drivers. Elevated delivery unit prices (YoY +9.3%) remain an ongoing issue. Received the Green Logistics Excellent Business Award (Minister of Land, Infrastructure, Transport and Tourism Award), achieving improvements in delivery efficiency and CO2 reduction (annual reduction of 18.9%).
Full-year forecast is maintained at sales of 1.23 trillion yen (+3.5%), operating income of 290 hundred million yen (+3.5%), and net income of 220 hundred million yen (-3.8%). Although inflation and frugal consumer behavior, as well as logistics cost increases due to labor shortages, are expected to persist, the company aims to achieve its full-year targets through account expansion, strengthening sales of value-added products, and SG&A control. In 2H, it plans to improve in-warehouse efficiency by utilizing externally leased centers and to restore operating CF. Priority measures are improving delivery efficiency (continued green logistics initiatives) and strengthening accounts receivable collection.
Management stated, "In a challenging environment for securing profits, we will execute measures to expand transactions and control SG&A." In the third quarter, in-warehouse work efficiency bottomed (piece-pick line productivity improved versus 2Q), and the company is securing medium- to long-term capacity by leasing external centers. On the delivery front, as rising delivery unit prices (+9.3%) remain an issue, it will continue to improve delivery efficiency through joint deliveries and stronger collaboration with external companies.
Win accounts and expand high value-added new product lines (e.g., health foods and out-of-home related items). Alleviate capacity constraints and improve in-warehouse efficiency by utilizing externally leased centers (structural shift from piece-pick to case shipments). Delivery efficiency initiatives: promote reductions in delivery runs and CO2 through green logistics (use of relay hubs, joint deliveries, collaboration with external companies). Maximize human capital value: refresh uniforms reflecting female employees’ perspectives and promote recycling via the workplace improvement initiative "Neo Rosy Project". SG&A control: promote improvement activities through stronger collaboration with retailers; reinforce accounts receivable collection (shorten DSO).
Persistent frugal spending due to inflation continues to restrain sales volume growth. Rising delivery costs and in-warehouse labor costs due to labor shortages continue to drive up the SG&A ratio (factors behind increases in the center fee rate and SG&A ratio). Increases in delivery unit prices (+9.3%) remain a burden and may not improve in the short term. Operating CF/net income ratio of 0.48 and cash conversion rate of 0.31 indicate insufficient cash realization of earnings (consistent with XBRL analysis). Front-loaded expenses associated with operating externally leased centers (rent, consumables, etc.) are compressing short-term margins.